How many studies have been conducted on Semaglutide?

BiohacksAI has indexed 1,000 PubMed studies on Semaglutide, including 240 randomized controlled trials (RCTs). 88% of studies involve human subjects.

What are the main research areas for Semaglutide?

The primary research domains for Semaglutide are 🔥 Metabolic, ❤️ Cardiovascular, 🧬 Hormones. This is based on analysis of 1,000 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Semaglutide

A glucagon-like peptide and GLP-1 agonist used to enhance glycemic control of TYPE 2 DIABETES MELLITUS, and for OBESITY MANAGEMENT.

1.0k+ PubMed studies analyzed · 240 RCTs · Evidence Score: 69.9

Research Domains

Semaglutide has been studied across 11 research domains including 🔥 Metabolic, ❤️ Cardiovascular, 🧬 Hormones, 🫘 Kidney, 🫁 Liver & Detox. The primary research focus is 🔥 Metabolic with 90% of studies addressing this area.

Loading evidence profile...

This evidence profile for Semaglutide is generated deterministically from 1,000 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.